We provide you with 20 years of free, institutional-grade data for AVEO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AVEO. Explore the full financial landscape of AVEO stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2022-11-07 | 0001325879 | AVEO | 10-Q | Url |
| 2022-08-04 | 0001325879 | AVEO | 10-Q | Url |
| 2022-05-05 | 0001325879 | AVEO | 10-Q | Url |
| 2022-03-14 | 0001325879 | AVEO | 10-K | Url |
| 2021-11-08 | 0001325879 | AVEO | 10-Q | Url |
| 2021-08-05 | 0001325879 | AVEO | 10-Q | Url |
| 2021-05-10 | 0001325879 | AVEO | 10-Q | Url |
| 2021-03-16 | 0001325879 | AVEO | 10-K | Url |
| 2020-11-09 | 0001325879 | AVEO | 10-Q | Url |
| 2020-08-10 | 0001325879 | AVEO | 10-Q | Url |
| 2020-04-30 | 0001325879 | AVEO | 10-Q | Url |
| 2020-03-16 | 0001325879 | AVEO | 10-K | Url |
| 2019-11-12 | 0001325879 | AVEO | 10-Q | Url |
| 2019-08-08 | 0001325879 | AVEO | 10-Q | Url |
| 2019-05-09 | 0001325879 | AVEO | 10-Q | Url |
| 2019-03-14 | 0001325879 | AVEO | 10-K | Url |
| 2018-11-09 | 0001325879 | AVEO | 10-Q | Url |
| 2018-08-07 | 0001325879 | AVEO | 10-Q | Url |
| 2018-05-08 | 0001325879 | AVEO | 10-Q | Url |
| 2018-03-13 | 0001325879 | AVEO | 10-K | Url |
| 2017-11-07 | 0001325879 | AVEO | 10-Q | Url |
| 2017-08-09 | 0001325879 | AVEO | 10-Q | Url |
| 2017-05-04 | 0001325879 | AVEO | 10-Q | Url |
| 2017-03-22 | 0001325879 | AVEO | 10-K | Url |
| 2016-11-04 | 0001325879 | AVEO | 10-Q | Url |
| 2016-08-04 | 0001325879 | AVEO | 10-Q | Url |
| 2016-05-10 | 0001325879 | AVEO | 10-Q | Url |
| 2016-03-15 | 0001325879 | AVEO | 10-K | Url |
| 2015-11-09 | 0001325879 | AVEO | 10-Q | Url |
| 2015-08-10 | 0001325879 | AVEO | 10-Q | Url |
| 2015-05-07 | 0001325879 | AVEO | 10-Q | Url |
| 2015-03-06 | 0001325879 | AVEO | 10-K | Url |
| 2014-11-05 | 0001325879 | AVEO | 10-Q | Url |
| 2014-08-11 | 0001325879 | AVEO | 10-Q | Url |
| 2014-05-07 | 0001325879 | AVEO | 10-Q | Url |
| 2014-03-13 | 0001325879 | AVEO | 10-K | Url |
| 2013-11-07 | 0001325879 | AVEO | 10-Q | Url |
| 2013-08-08 | 0001325879 | AVEO | 10-Q | Url |
| 2013-05-10 | 0001325879 | AVEO | 10-Q | Url |
| 2013-03-11 | 0001325879 | AVEO | 10-K | Url |
| 2012-11-08 | 0001325879 | AVEO | 10-Q | Url |
| 2012-08-07 | 0001325879 | AVEO | 10-Q | Url |
| 2012-05-09 | 0001325879 | AVEO | 10-Q | Url |
| 2012-03-30 | 0001325879 | AVEO | 10-K | Url |
| 2011-11-08 | 0001325879 | AVEO | 10-Q | Url |
| 2011-08-09 | 0001325879 | AVEO | 10-Q | Url |
| 2011-05-12 | 0001325879 | AVEO | 10-Q | Url |
| 2011-03-11 | 0001325879 | AVEO | 10-K | Url |
| 2010-11-10 | 0001325879 | AVEO | S-1 | Url |
| 2010-11-05 | 0001325879 | AVEO | 10-Q | Url |
| 2010-08-06 | 0001325879 | AVEO | 10-Q | Url |
| 2010-05-13 | 0001325879 | AVEO | 10-Q | Url |
| 2009-12-16 | 0001325879 | AVEO | S-1 | Url |
AVEO Pharmaceuticals, Inc(NASDAQ:AVEO) 
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of ren...
Website: http://www.aveooncology.com
Founded: 2001
Full Time Employees: 49 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about AVEO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.